KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 111 filers reported holding KRYSTAL BIOTECH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,017,519 | +46.6% | 17,185 | 0.0% | 1.52% | +41.3% |
| Q1 2023 | $1,375,831 | +1.1% | 17,185 | 0.0% | 1.07% | +4.5% |
| Q4 2022 | $1,361,396 | +13.6% | 17,185 | 0.0% | 1.03% | +0.4% |
| Q3 2022 | $1,198,000 | +6.2% | 17,185 | 0.0% | 1.02% | +12.8% |
| Q2 2022 | $1,128,000 | -1.3% | 17,185 | 0.0% | 0.91% | +18.7% |
| Q1 2022 | $1,143,000 | -4.9% | 17,185 | 0.0% | 0.76% | +0.3% |
| Q4 2021 | $1,202,000 | +32.5% | 17,185 | -1.1% | 0.76% | +14.1% |
| Q3 2021 | $907,000 | -22.8% | 17,376 | +0.6% | 0.67% | -22.7% |
| Q2 2021 | $1,175,000 | -11.3% | 17,277 | +0.5% | 0.86% | -18.2% |
| Q1 2021 | $1,324,000 | +25.5% | 17,192 | -2.2% | 1.06% | +16.6% |
| Q4 2020 | $1,055,000 | +29.8% | 17,586 | -6.9% | 0.91% | +23.8% |
| Q3 2020 | $813,000 | +13.1% | 18,894 | +8.8% | 0.73% | -7.3% |
| Q2 2020 | $719,000 | – | 17,369 | – | 0.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 771,250 | $53,949,000 | 4.15% |
| First Light Asset Management, LLC | 680,170 | $47,578,000 | 3.41% |
| ACT CAPITAL MANAGEMENT, LLC | 59,000 | $4,127,000 | 2.98% |
| S Squared Technology, LLC | 95,215 | $6,660,000 | 2.98% |
| Redmile Group, LLC | 1,820,898 | $127,372,000 | 2.90% |
| Soleus Capital Management, L.P. | 228,437 | $15,979,000 | 1.60% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 50,922 | $3,562,000 | 1.59% |
| Artal Group S.A. | 700,000 | $48,965,000 | 1.33% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 46,670 | $3,265,000 | 1.32% |
| Kynam Capital Management, LP | 34,816 | $2,435,000 | 1.30% |